Upon completion of this activity, participants should be able to:
- Describe the immunopathology of adverse drug reactions including the Gell & Coombs classification system, pseudoallergic reactions, and the hapten hypothesis
- Define contraindications to re-exposure to medications implicated in drug allergy including serious cutaneous adverse reactions (SCARs) and end-organ dysfunction (hemolytic anemia, drug induced lupus, etc).
- Describe the role of skin testing, graded dose challenge and desensitization in the evaluation and treatment of patients with drug allergy
Kara Wada, MD
The Ohio State University
Iris Otani, MD
UCSF Medical Center